Posts tagged Funding
The Magnificent Seven Life Science Startups Hitting London this Summer

Exciting life sciences startups from around the world are kicking off their acceleration in London
this week. RebelBio, the world’s first life sciences accelerator and owned by SOSV, has taken
on seven companies for Cohort VI and they are working on some extremely innovative and
disruptive tech. Whether you are into sustainability in the food sector, artificial intelligence and
machine learning, neurodegenerative disease or the microbiome (to name a few) there is
something here that you’ll want to follow. These companies include science lovers from a range
of backgrounds, including BScs, MBAs, PhDs, doctors, surgeons, CEOs and visionaries, who
are being thrust into a full-on three month programme including investment, mentorship and
business training with RebelBio.

Read More
A startup from London brings personalised epigenetic testing directly to the everyday consumer.

As part of this month’s #genomejuly topic I was interested in the advances of the epigenome innovations in the biotech industry. I, therefore, recently spoke with Chronomics CEO, Dr. Tom Stubbs. Chronomics is a startup that brings personalised epigenetic testing directly to the everyday consumer. They offer a saliva test that will enable you to track epigenetic changes as a consequence of your diet, environment and lifestyle. Epigenetics is the study of alterations in the expression of genes without direct changes to the genetic code itself. During this month’s interview we spoke about Chronomics’ development and their realization in of the potential of epigenetic testing for personal health. I discussed with Tom the key challenges Chronomics overcame in their growth as an early-stage biotech company and his advice to aspiring entrepreneurs in the life sciences.

Read More
Innovation in the human microbiome

The human body contains trillions of micro-organisms, with an estimated 3.8∙10^13 bacterial cells accounting for up to 0.2 kg of body weight (Sender, R. et al., 2016). These microbes live within us in a symbiotic relationship and research has led to the understanding that they prove vital to our physiological functions. As vital as they are in remaining healthy, they are highly associated with causing or contributing to the development of many chronic diseases. These microbes are collectively known as ‘the human microbiota’ and the ‘microbiome’ is the term which describes the genes of all these microbes. The microbiome is unique to every individual and the extent to which it affects vital bodily functions is only just beginning to be really understood.

Read More
UK’s first online marketplace for scientists breaks down barriers to entry for life science start-ups

For the first time , companies and scientists will be able to book expertise, lab space and equipment outside their institution via an online platform, creating a new dawn for independent life science research in the UK.

Clustermarket (www.clustermarket.com) has launched in partnership with Merck Accelerator as the UK’s first online marketplace for scientists – enabling grassroots scientific research and ‘access for all’ in life sciences.

Read More